• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RHYTHMIA HDXTM MAPPING SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RHYTHMIA HDXTM MAPPING SYSTEM; COMPUTER, DIAGNOSTIC, PROGRAMMABLE Back to Search Results
Model Number 87042
Device Problem Data Problem (3196)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/10/2021
Event Type  malfunction  
Manufacturer Narrative
The device has not been received for analysis.Upon receipt and completion of the failure analysis of the complaint device, if there is any further relevant information from that review, a supplemental medwatch will be filed.
 
Event Description
It was reported that during a left atrial flutter procedure, using the rhythmia mapping system, the procedure took place in a different operating theater than usual, because the usual one is being renovated.When inserting the orion catheter inside the patient's body, it was able to be correctly visualized on the rhythmia system following its path to the inferior vena cava.When the catheter arrived on the cavotricuspid isthmus line (cti), it was still able to be visualized.When the physician moved the catheter more superiorly, it was not visible anymore on the rhythmia system.No error message was shown.The fluoroscopy system and the echography machine were moved away, but nothing changed.The catheter was inside tracking region.The hypothesis is that the table used for procedure was creating distortion on magnetic field.A map was created that validated the previously ablated cti block due to left atrial flutter, but the map was not possible to finish the right atrium map because the catheter disappeared as soon as it moved inside the right atrium.As a result, it was not possible to map the left atrium and evaluate the tachycardia mechanism.The physician decided to terminate the atrial flutter ablation procedure as the map was unable to be completed.Cardioversion was performed to return the patient to sinus rhythm.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RHYTHMIA HDXTM MAPPING SYSTEM
Type of Device
COMPUTER, DIAGNOSTIC, PROGRAMMABLE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
4100 hamline ave n
arden hills MN 55112 5798
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key12409460
MDR Text Key269470011
Report Number2134265-2021-11123
Device Sequence Number1
Product Code DQK
Combination Product (y/n)N
Reporter Country CodeFR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 09/01/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number87042
Device Catalogue Number87042
Device Lot Number1000000164
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/10/2021
Initial Date FDA Received09/01/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/18/2017
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-